Tribulus Terrestris for Treatment of Sexual Dysfunction in Women: Randomized Double-Blind Placebo - Controlled Study.

Akhtari Elham, et al.
DARU Journal of Pharmaceutical Sciences, 2014

Abstract

Background

Tribulus terrestris as a herbal remedy has shown beneficial aphrodisiac effects in a number of animal and human experiments. This study was designed as a randomized double-blind placebo-controlled trial to assess the safety and efficacy of Tribulus terrestris in women with hypoactive sexual desire disorder during their fertile years. Sixty seven women with hypoactive sexual desire disorder were randomly assigned to Tribulus terrestris extract (7.5 mg/day) or placebo for 4 weeks. Desire, arousal, lubrication, orgasm, satisfaction, and pain were measured at baseline and after 4 weeks after the end of the treatment by using the Female Sexual Function Index (FSFI). Two groups were compared by repeated measurement ANOVA test.

Results

Thirty women in placebo group and thirty women in drug group completed the study. At the end of the fourth week, patients in the Tribulus terrestris group had experienced significant improvement in their total FSFI (p < 0.001), desire (p < 0.001), arousal (p = 0.037), lubrication (p < 0.001), satisfaction (p < 0.001) and pain (p = 0.041) domains of FSFI. Frequency of side effects was similar between the two groups.

Conclusions

Tribulus terrestris may safely and effectively improve desire in women with hypoactive sexual desire disorder. Further investigation of Tribulus terrestris in women is warranted.

PMID:24773615
DOI:10.1186/2008-2231-22-40
PMCID (Free PMC Article):PMC4045980
Category: Female Aphrodisiac

The best supplements with Tribulus Terrestris in Female Aphrodisiac category:

Previous article

Evaluation of the Efficacy and Safety of Tribulus Terrestris in Male Sexual dysfunction-A Prospective, Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

Next article

Efficacy of Tribulus Terrestris for the Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women: A Randomized, Double-Blinded, Placebo-Controlled Trial.